Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Title: A Multicenter, Prospective, Modified Platform Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers.

NCT07665268 is registered in ClinicalTrials.gov with Sequence LifeScience, Inc. as lead sponsor.

NCT NCT07665268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07665268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Title: A Multicenter, Prospective, Modified Platform Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers.
Lead sponsor
Sequence LifeScience, Inc.
Phase
Phase 4
Overall status
Recruiting
Start date
January 28, 2026
Completion date
January 28, 2028
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic ulcer, pressure sore, pressure ulcer (pu), pressure ulcer of skin, pressure wound, skin ulcer